Boehringer Ingelheim today announced the start of a Phase IIa clinical trial evaluating BI 765423, a novel monoclonal antibody targeting interleukin-11 (IL-11), in patients with idiopathic pulmonary ...
Here are the 40 Under 40 winners this year and an outstanding alumnus who is entering the Hall of Fame.
SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- ...
Jeff Ruby Culinary Entertainment has agreed to pay more than $1.5 million to settle a class action federal labor lawsuit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback